Johnson & Johnson's Fiscal Year is From January To December.
The item "Fixed-Asset-Turnover" stands at 3.16 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of Johnson & Johnson's third quarter, the item "Fixed Asset Turnover" stands at 3.16. This represents a decrease of -26.98 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -28.19 percent compared to the value the year prior.
The 1 year change in percent is -28.19.
The 3 year change in percent is -39.03.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Fixed Asset Turnover | 905,699,262,464.00 |
![]() | AbbVie Inc - Fixed Asset Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Fixed Asset Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Fixed Asset Turnover | 280,205,508,085.11 |
![]() | Novartis AG - Fixed Asset Turnover | 255,096,620,580.91 |